NordiQC Assessment-HER2 IHC mAb clone C1F7

2020-08-18

By snt_manager

Share to:

Celnovte Biotechnology HER2 IHC-mAb clone C1F7 has got Nordic immunohistochemical quality control. The quality of our products are strictly controlled. More assessment details about HER2 IHC-mAb clone C1F7, please see pictures and the website. Welcome to tell us your demands and contact us on email info@celnovte-bio-tech.com.

Celnovte CE Mark Approved

Celnovte NordiQC Assessment-CD15/CD56/CDX2